Home » Medical Devices » Photopheresis Products Market

Photopheresis Products Market By Type (Closed System, Open System), By Therapeutic Area (Cutaneous T-Cell Lymphoma, Solid Organ Transplant Rejections, Autoimmune Diseases, Graft Versus Host Diseases) – Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

Summary
Table Of Content

Market Insights:

Therapeutic apheresis has been present in the healthcare system for several years, dating back to the 1950s. Currently, apheresis and its modalities are acknowledged as effective first-line treatments or adjunctive treatments for a wide range of disorders. Some common therapeutic apheresis modalities include plasmapheresis, leukapheresis, blood cell apheresis, lipid apheresis, platelet apheresis, and photopheresis. Photopheresis, also known as extracorporeal phototherapy, is gaining new popularity in the market, particularly due to its growing demand in off-label applications and greater efficacy in treating graft versus host disease and preventing organ transplant rejection.

Market Synopsis

Graft Versus Host Disease to Lead the Market in Terms of Revenue

Over half of the cost incurred in transplantation is consumed by post-transplant care costs, mainly including immunosuppressive therapies. As a majority of transplant patients develop episodes of chronic rejection, insurance companies are keen to consider management therapies such as photopheresis for patients that do not respond to conventional immunosuppressive therapies. Additionally, more than half of patients receiving allogeneic bone marrow transplants develop graft versus host disease. Photopheresis is reported to respond positively in the majority of graft-versus-host conditions and cases of organ transplant rejection. Therefore, with growing evidence in support of the efficacy of photopheresis, more recommendations from physicians and surgeons will occur, which will augment the market growth for photopheresis products.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Sustained Demand for Closed Systems to Support the Photopheresis Products Market Growth

The first system for photopheresis approved by the FDA was the UVAR by Therakos, a closed system (1988). Since then, several open and closed systems have been approved worldwide for clinical use. Open photopheresis systems use separate compartments for cell separation and photoactivation. As different steps are involved in therapy administration, there is, therefore, a high risk of contamination or patient re-infusion error. Thus, open tubes are only used in certified centers for the separate handling of blood components. However, closed systems do not face this limitation and are therefore widely used, ensuring their sustained demand and dominance in the global market.

Widespread Presence of Apheresis Centers: Ensuring the Supremacy of North America

Currently, North America dominates the global photopheresis market. The early introduction of apheresis and its subsequent modalities, as well as the widespread presence of advanced apheresis and blood processing centers, are the primary factors driving North America’s prominent position on the global front. Greater affordability in the patient population, facilitated by the favorable reimbursement scenario, further contributes to the dominance of North America. However, striations in the region have resulted in a diversion of manufacturers’ attention to the emerging markets of Asia Pacific and Latin America. The Asia Pacific market is mainly characterized by widening outreach of healthcare infrastructure, increasing disposable incomes in the patient population, growing awareness, and rapid approvals for advanced treatments. The global photopheresis products market is fragmented but competitive. The players are mainly identified by their product differentiation. Some prime companies engaged in this space are Terumo Corporation, Mallinckrodt Pharmaceuticals, Fresenius Kabi AG, Macopharma, Haemonetics Corporation, and others.

Periods of History and Forecast

2016 is a historic year.

2017: Base Year

2018-2026: Forecast Period

This study offers an analysis of every mentioned segment for the period from 2016 to 2026 while considering 2017 as the base year for further forecasting. Moreover, compounded annual growth rates (CAGRs) for every segment are covered and calculated for the period from 2018 to 2026.

Report Scope by Segments

This report on photopheresis products offers a quantitative assessment in terms of current and future market size, along with a qualitative analysis considering market dynamics and the competitive environment. For this purpose, the market is segmented by product types, therapeutic areas, and geographical distribution.

Type (2016-2026; millions of dollars)

Closed System
Open System

By therapeutic area (2016-2026; million US dollars),

Cutaneous T-cell lymphoma
solid organ transplant rejections
Autoimmune Diseases
Diseases of Graft Versus Host

Geography Segment (2016-2026; millions of dollars)

North America

- U.S.
- Canada
Europe
- U.K.
- Germany
- Rest of Europe
Asia-Pacific (APAC)
- China
- Japan
- Rest of APAC
Latin America (LATAM)
- Brazil
- Mexico
- rest of Latin America
Middle East and Africa (MEA)
- GCC
- Rest of the Middle East and Africa

The market trends prevalent in the global market for photopheresis products are scrutinized while considering the current and future roadmaps of the market. Assessment of market dynamics, such as drivers, restraints, and opportunities, provides an understanding of the market’s pros and cons. This report also assesses the positions of the major market players and offers their brief profiles based on their business overviews, product portfolios relevant to the market, financial information, and key developments. The players profiled in this report include Asahi Spectra USA, Inc., Avantes BV, Cogentix Medical, Inc. (LABORIE Medical Technologies), Hamamatsu Photonics K.K., Karlstrom SE & Co. KG, Ocean Optics, Inc., Olympus Medical Systems (Olympus Corporation), SOPRO-COMEG GmbH, Smith & Nephew Plc, Stryker Corporation, and Excelitas Technologies Corp.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key questions are answered in this report.

What is the current status of the photopheresis products market in 2017?
How will the market progress through the forecast period?
What are the major drivers and challenges prevalent in the global market for photopheresis products?
Which product type currently governs the market, and what will be its status over the forecast period?
Which therapeutic area is expected to witness the fastest growth during the forecast period?
What is the current status of the Asia-Pacific market in the global market for photopheresis products?
Will the market position of North America be challenged by Asia Pacific within the forecast period?
What is the current competitive scenario in the global market?
Which are the major strategies employed by the market players to strengthen their positions?

Chapter 1 Preface
1.1 Report Scope and Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Approach Adopted
1.3.4 Top-Down Approach
1.3.5 Bottom-Up Approach
1.3.6 Phase III – Expert Panel Review
1.3.7 Assumptions
1.4 Market Segmentation

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Photopheresis Products Market
2.1.1 Global Photopheresis Products Market, by Type, 2017 (US$ Mn)
2.1.2 Global Photopheresis Products Market, by Therapeutic Area, 2017 (US$ Mn)
2.1.3 Global Photopheresis Products Market, by Geography, 2017 (US$ Mn)

Chapter 3 Photopheresis Products: Market Dynamics and Outlook
3.1 Introduction
3.2 Market Drivers
3.2.1 XXXX XXXX XXXX XXXX XXXX
3.2.1 Driver 2
3.3 Challenges
3.3.1 Challenge 1
3.3.2 Challenge 2
3.4 Opportunities
3.4.1 Opportunity 1
3.5 Attractive Investment Proposition, by Geography, 2017
3.6 Competitive Landscape, by Key Players, 2017

Chapter 4 Global Photopheresis Products Market, by Type
4.1 Overview
4.2 Closed System
4.3 Open System

Chapter 5 Global Photopheresis Products Market, by Therapeutic Area
5.1 Overview
5.2 Cutaneous T-cell Lymphoma
5.3 Solid Organ Transplant Rejections
5.4 Autoimmune Diseases
5.5 Graft Versus Host Diseases

Chapter 6 Global Photopheresis Products Market, by Geography
6.1 Overview
6.2 North America
6.2.1 North America Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
6.2.2 North America Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
6.2.3 North America Photopheresis Products Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1 U.S.
6.2.3.1.1 U.S. Photopheresis Products Market, by Type, 2016-2026 (US$ Mn)
6.2.3.1.2 U.S. Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.2.3.2 Canada
6.2.3.2.1 Canada Photopheresis Products Market, by Type, 2016-2026 (US$ Mn)
6.2.3.2.2 Canada Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.3 Europe
6.3.1 Europe Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
6.3.2 Europe Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
6.3.3 Europe Photopheresis Products Market, by Country/Region (US$ Mn)
6.3.3.1 U.K.
6.3.3.1.1 U.K. Photopheresis Products Market, by Type, 2016-2026 (US$ Mn)
6.3.3.1.2 U.K. Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.3.3.2 Germany
6.3.3.2.1 Germany Photopheresis Products Market, by Type, 2016-2026 (US$ Mn)
6.3.3.2.2 Germany Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.3.3.3 Rest of Europe
6.3.3.3.1 Rest of Europe Photopheresis Products Market, by Type, 2016-2026 (US$ Mn)
6.3.3.3.2 Rest of Europe Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.4 Asia Pacific
6.4.1 Asia Pacific Photopheresis Products Market by Type, 2016-2026 (US$ Mn)
6.4.2 Asia Pacific Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.4.3 Asia Pacific Photopheresis Products Market, by Country/Region, 2016-2026 (US$ Mn)
6.4.3.1 Japan
6.4.3.1.1 Japan Photopheresis Products Market by Type, 2016-2026 (US$ Mn)
6.4.3.1.2 Japan Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.4.3.2 China
6.4.3.2.1 China Photopheresis Products Market by Type, 2016-2026 (US$ Mn)
6.4.3.2.2 China Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.4.3.3 Rest of Asia Pacific
6.4.3.3.1 Rest of Asia Pacific Photopheresis Products Market by Type, 2016-2026 (US$ Mn)
6.4.3.3.2 Rest of Asia Pacific Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.5 Latin America
6.5.1 Latin America Photopheresis Products Market by Type, 2016-2026 (US$ Mn)
6.5.2 Latin America Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.5.3 Latin America Photopheresis Products Market, by Country/Region, 2016-2026 (US$ Mn)
6.5.3.1 Brazil
6.5.3.1.1 Brazil Photopheresis Products Market by Type, 2016-2026 (US$ Mn)
6.5.3.1.2 Brazil Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.5.3.2 Mexico
6.5.3.2.1 Mexico Photopheresis Products Market by Type, 2016-2026 (US$ Mn)
6.5.3.2.2 Mexico Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.5.3.3 Rest of Latin America
6.5.3.3.1 Rest of Latin America Photopheresis Products Market by Type, 2016-2026 (US$ Mn)
6.5.3.3.2 Rest of Latin America Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.6 Middle East & Africa
6.6.1 Middle East & Africa Photopheresis Products Market by Type, 2016-2026 (US$ Mn)
6.6.2 Middle East & Africa Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.6.3 Middle East & Africa Photopheresis Products Market, by Region, 2016-2026 (US$ Mn)
6.6.3.1 GCC
6.6.3.1.1 GCC Photopheresis Products Market by Type, 2016-2026 (US$ Mn)
6.6.3.1.2 GCC Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)
6.6.3.2 Rest of Middle East & Africa
6.6.3.2.1 Rest of Middle East & Africa Photopheresis Products Market by Type, 2016-2026 (US$ Mn)
6.6.3.2.2 Rest of Middle East & Africa Photopheresis Products Market, by Therapeutic Area, 2016-2026 (US$ Mn)

Chapter 7 Company Profiles
7.1 Haemonetics Corporation
7.2 Fresenius Kabi AG
7.3 Macopharma
7.4 Mallinckrodt Pharmaceuticals
7.5 Med Tech Solutions GmbH
7.6 Terumo Corporation

List of Figures

FIG. 1 Global Photopheresis Products Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Photopheresis Products Market Segmentation
FIG. 4 Global Photopheresis Products Market, by Type, 2017 (US$ Mn)
FIG. 5 Global Photopheresis Products Market, by Therapeutic Area, 2017 (US$ Mn)
FIG. 6 Global Photopheresis Products Market, by Geography, 2017 (US$ Mn)
FIG. 7 Attractive Investment Proposition, by Geography, 2017
FIG. 8 Global Market Positioning of Key Photopheresis Products Manufacturers, 2017
FIG. 9 Global Closed System Photopheresis Products Market, 2016 – 2026 (US$ Mn)
FIG. 10 Global Open System Photopheresis Products Market, 2016 – 2026 (US$ Mn)
FIG. 11 Global Photopheresis Products Market for Cutaneous T-Cell Lymphoma, 2016 – 2026 (US$ Mn)
FIG. 12 Global Photopheresis Products Market for Solid Organ Transplant Rejections, 2016 – 2026 (US$ Mn)
FIG. 13 Global Photopheresis Products Market for Autoimmune Diseases, 2016 – 2026 (US$ Mn)
FIG. 14 Global Photopheresis Products Market for Graft Versus Host Diseases, 2016 – 2026 (US$ Mn)

List of Tables

TABLE 1 Market Snapshot: Global Photopheresis Products Market Volume
TABLE 2 Market Snapshot: Global Photopheresis Products Market Value
TABLE 3 Global Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global Photopheresis Products Market, by Therapeutic Area 2016 – 2026 (US$ Mn)
TABLE 5 Global Photopheresis Products Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 6 North America Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 7 North America Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 8 North America Photopheresis Products Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 9 U.S. Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 10 U.S. Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 11 Canada Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 12 Canada Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 13 Europe Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 14 Europe Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 15 Europe Photopheresis Products Market, by Country/Region 2016 – 2026 (US$ Mn)
TABLE 16 U.K. Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 17 U.K. Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 18 Germany Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 19 Germany Photopheresis Products Market, by Therapeutic Area 2016 – 2026 (US$ Mn)
TABLE 20 Rest of Europe Photopheresis Products Market Value, by Type, 2016 – 2026 (US$ Mn)
TABLE 21 Rest of Europe Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 22 Asia Pacific Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 23 Asia Pacific Photopheresis Products Market, by Therapeutic Area 2016 – 2026 (US$ Mn)
TABLE 24 Asia Pacific Photopheresis Products Market, by Country/Region 2016 – 2026 (US$ Mn)
TABLE 25 Japan Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 26 Japan Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 27 China Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 28 China Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 29 Rest of Asia Pacific Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 30 Rest of Asia Pacific Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 31 Latin America Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 32 Latin America Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 33 Brazil Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 34 Brazil Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 35 Mexico Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 36 Mexico Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 37 Rest of Latin America Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 38 Rest of Latin America Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 39 Middle East & Africa Photopheresis Products Market Value, by Type, 2016 – 2026 (US$ Mn)
TABLE 40 Middle East & Africa Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 41 GCC Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 42 GCC Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 43 Rest of Middle East & Africa Photopheresis Products Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 44 Rest of Middle East & Africa Photopheresis Products Market, by Therapeutic Area, 2016 – 2026 (US$ Mn)
TABLE 45 Haemonetics Corporation: Company Snapshot (Business Description; Product Portfolio; Financial Information; Recent Development)
TABLE 46 Fresenius Kabi AG: Company Snapshot (Business Description; Product Portfolio; Financial Information; Recent Development)
TABLE 47 Macopharma: Company Snapshot (Business Description; Product Portfolio; Financial Information; Recent Development)
TABLE 48 Mallinckrodt Pharmaceuticals: Company Snapshot (Business Description; Product Portfolio; Financial Information; Recent Development)
TABLE 49 Med Tech Solutions GmbH: Company Snapshot (Business Description; Product Portfolio; Financial Information; Recent Development)
TABLE 50 Terumo Corporation: Company Snapshot (Business Description; Product Portfolio; Financial Information; Recent Development)

Frequently Asked Questions:

What is the size of Photopheresis Products Market?

The market for Photopheresis Products is expected to reach US$ 418.56 Mn in 2026.

What is the Photopheresis Products Market CAGR?

The Photopheresis Products market is expected to see significant CAGR growth over the coming years,at 5.5%.

What is the Forecast period considered for Photopheresis Products Market?

The report is forecasted from 2018-2026.

What is the base year considered for Photopheresis Products Market?

The base year of this report is 2017.

Who are the major players in this Market?

Haemonetics Corporation, Fresenius Kabi AG, Macopharma, Mallinckrodt Pharmaceuticals, Med Tech Solutions GmbH are some of the major players in the global market.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –